Introducing our new podcast series – HEART TO HEART. This series will explore patients' journeys with cardio-oncology care through conversations with their health care providers.
🎧 Tune In: tinyurl.com/icos-h2h
#cardioonc #podcast #cardiooncology #cardiooncologie #cardiooncologia
🎧 Tune In: tinyurl.com/icos-h2h
#cardioonc #podcast #cardiooncology #cardiooncologie #cardiooncologia
February 13, 2025 at 4:54 PM
Introducing our new podcast series – HEART TO HEART. This series will explore patients' journeys with cardio-oncology care through conversations with their health care providers.
🎧 Tune In: tinyurl.com/icos-h2h
#cardioonc #podcast #cardiooncology #cardiooncologie #cardiooncologia
🎧 Tune In: tinyurl.com/icos-h2h
#cardioonc #podcast #cardiooncology #cardiooncologie #cardiooncologia
#APICAT trial at #ACC25 #LBCT #cardioonc
🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint recurrent VTE
🩸more than half female! 👏🏽👏🏽
🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed
🩸no increase in deaths
🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint recurrent VTE
🩸more than half female! 👏🏽👏🏽
🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed
🩸no increase in deaths
March 29, 2025 at 3:34 PM
#APICAT trial at #ACC25 #LBCT #cardioonc
🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint recurrent VTE
🩸more than half female! 👏🏽👏🏽
🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed
🩸no increase in deaths
🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint recurrent VTE
🩸more than half female! 👏🏽👏🏽
🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed
🩸no increase in deaths
A #JACCCardioOnc perspective from Dr. @vijayrao7474.bsky.social, et al outlines the current state of #CardioOnc quality assessment and proposes a roadmap for meaningful metrics to improve care.
Get the details: bit.ly/3YhYnll #ACCCardioOnc @icosociety.bsky.social
Get the details: bit.ly/3YhYnll #ACCCardioOnc @icosociety.bsky.social
April 29, 2025 at 1:41 PM
A #JACCCardioOnc perspective from Dr. @vijayrao7474.bsky.social, et al outlines the current state of #CardioOnc quality assessment and proposes a roadmap for meaningful metrics to improve care.
Get the details: bit.ly/3YhYnll #ACCCardioOnc @icosociety.bsky.social
Get the details: bit.ly/3YhYnll #ACCCardioOnc @icosociety.bsky.social
QT Prolongation in Oncology: Practical Playbook, Risk–Benefit Balance, and the Road Ahead at GCOS 2025
@icosociety.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #CardioOncology
@icosociety.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #CardioOncology
QT Prolongation in Oncology: Practical Playbook, Risk–Benefit Balance, and the Road Ahead at GCOS 2025 - OncoDaily
QT Prolongation in Oncology: Practical Playbook, Risk–Benefit Balance, and the Road Ahead at GCOS 2025 / cancer, Cardio-Oncology, cardiology and oncology,
oncodaily.com
November 4, 2025 at 8:37 PM
QT Prolongation in Oncology: Practical Playbook, Risk–Benefit Balance, and the Road Ahead at GCOS 2025
@icosociety.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #CardioOncology
@icosociety.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #CardioOncology
Excited to have @jennkwanMDPhD come talk at our Stanford Cardio-Onc conference today at 4-5 pm PST on Zoom! See you all there! @Paul_P_Cheng @StanfordCVI @SeanM_Wu @Ron_Witteles #cardioonc
March 11, 2025 at 6:58 PM
Excited to have @jennkwanMDPhD come talk at our Stanford Cardio-Onc conference today at 4-5 pm PST on Zoom! See you all there! @Paul_P_Cheng @StanfordCVI @SeanM_Wu @Ron_Witteles #cardioonc
Cancer Incidence & Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort
#CardioSky #CardioOnc #MedSky #JACCCardioOnc
@jaccjournals.bsky.social @accintouch.bsky.social @avirupguha.bsky.social @robmentz.bsky.social @dranulala.bsky.social
www.jacc.org/doi/10.1016/...
#CardioSky #CardioOnc #MedSky #JACCCardioOnc
@jaccjournals.bsky.social @accintouch.bsky.social @avirupguha.bsky.social @robmentz.bsky.social @dranulala.bsky.social
www.jacc.org/doi/10.1016/...
December 6, 2024 at 2:24 PM
Cancer Incidence & Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort
#CardioSky #CardioOnc #MedSky #JACCCardioOnc
@jaccjournals.bsky.social @accintouch.bsky.social @avirupguha.bsky.social @robmentz.bsky.social @dranulala.bsky.social
www.jacc.org/doi/10.1016/...
#CardioSky #CardioOnc #MedSky #JACCCardioOnc
@jaccjournals.bsky.social @accintouch.bsky.social @avirupguha.bsky.social @robmentz.bsky.social @dranulala.bsky.social
www.jacc.org/doi/10.1016/...
In a roundtable discussion, Drs. Eric H. Yang and Ashley Stein-Merlob from the UCLA Cardio-Oncology Program do a deep dive into building a #cardioonc practice
citoday.com/articles/202...
citoday.com/articles/202...
Building a Cardio-Oncology Practice - Cardiac Interventions Today
A discussion of first steps, getting buy-in from administration and colleagues, essential support staff and service lines, building and maintaining relationships, obtaining referrals, raising awarenes...
citoday.com
June 16, 2025 at 1:41 PM
In a roundtable discussion, Drs. Eric H. Yang and Ashley Stein-Merlob from the UCLA Cardio-Oncology Program do a deep dive into building a #cardioonc practice
citoday.com/articles/202...
citoday.com/articles/202...
Dr. Isabelle Mahe on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE
#ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag #CardioSky
#ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag #CardioSky
March 29, 2025 at 3:29 PM
Dr. Isabelle Mahe on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE
#ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag #CardioSky
#ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag #CardioSky
Global Cardio-Oncology Summit (GC-OS) 2025: Access to Oncology Care. A Global Perspective
@icosociety.bsky.social
oncodaily.com/library/400920
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #Cardiooncology #Cardiooncologia
@icosociety.bsky.social
oncodaily.com/library/400920
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #Cardiooncology #Cardiooncologia
Access to Oncology Care. A Global Perspective
Access to oncology care remains unequal worldwide. GC-OS 2025 called for equity, prevention, and sustainable cancer care systems.
oncodaily.com
October 31, 2025 at 1:35 PM
Global Cardio-Oncology Summit (GC-OS) 2025: Access to Oncology Care. A Global Perspective
@icosociety.bsky.social
oncodaily.com/library/400920
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #Cardiooncology #Cardiooncologia
@icosociety.bsky.social
oncodaily.com/library/400920
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #Cardiooncology #Cardiooncologia
Today's highlights from ACC's #CardioOnc:
☑️ Significant reductions in cardiac dose w/ improved radiation therapy
☑️ TKI cardiomyopathy may be reversible w/ GDMT & 🔎 monitoring
☑️ Breast cancer survivors are at an ↗️ long-term CV risk
☑️ And more!
#ACCCardioOnc #CardioSky #MedSky
☑️ Significant reductions in cardiac dose w/ improved radiation therapy
☑️ TKI cardiomyopathy may be reversible w/ GDMT & 🔎 monitoring
☑️ Breast cancer survivors are at an ↗️ long-term CV risk
☑️ And more!
#ACCCardioOnc #CardioSky #MedSky
February 15, 2025 at 10:17 PM
Today's highlights from ACC's #CardioOnc:
☑️ Significant reductions in cardiac dose w/ improved radiation therapy
☑️ TKI cardiomyopathy may be reversible w/ GDMT & 🔎 monitoring
☑️ Breast cancer survivors are at an ↗️ long-term CV risk
☑️ And more!
#ACCCardioOnc #CardioSky #MedSky
☑️ Significant reductions in cardiac dose w/ improved radiation therapy
☑️ TKI cardiomyopathy may be reversible w/ GDMT & 🔎 monitoring
☑️ Breast cancer survivors are at an ↗️ long-term CV risk
☑️ And more!
#ACCCardioOnc #CardioSky #MedSky
Delighted to interview the co-chair of the ESC cardio-oncology guidelines #DrAlexLyon about his career in #CardioOnc #cardiology #oncology #cancer
Podcast Episode: JACC: CardioOncology Pulse - Cardio-Oncology Past, Present, and Future
gbr01.safelinks.protection.outlook.com?url=https%3A...
Podcast Episode: JACC: CardioOncology Pulse - Cardio-Oncology Past, Present, and Future
gbr01.safelinks.protection.outlook.com?url=https%3A...
January 31, 2025 at 7:51 AM
Delighted to interview the co-chair of the ESC cardio-oncology guidelines #DrAlexLyon about his career in #CardioOnc #cardiology #oncology #cancer
Podcast Episode: JACC: CardioOncology Pulse - Cardio-Oncology Past, Present, and Future
gbr01.safelinks.protection.outlook.com?url=https%3A...
Podcast Episode: JACC: CardioOncology Pulse - Cardio-Oncology Past, Present, and Future
gbr01.safelinks.protection.outlook.com?url=https%3A...
In our latest digital exclusive series, we explore cardio-oncology from the lens of the interventional cardiologist. Read more here! #cardioonc
Cardio-Oncology in the Cath Lab
The role of the interventional cardiologist, building a practice, and the future of the subspecialty.
www.linkedin.com
June 5, 2025 at 3:46 PM
In our latest digital exclusive series, we explore cardio-oncology from the lens of the interventional cardiologist. Read more here! #cardioonc
We have a busy Fall / Winter conference season ahead of us.
Join one of these important events virtually or in a location near you.
See all events: ic-os.org/events
#cardioonc #cardiooncology #healthcareconference
Join one of these important events virtually or in a location near you.
See all events: ic-os.org/events
#cardioonc #cardiooncology #healthcareconference
September 15, 2025 at 5:09 PM
We have a busy Fall / Winter conference season ahead of us.
Join one of these important events virtually or in a location near you.
See all events: ic-os.org/events
#cardioonc #cardiooncology #healthcareconference
Join one of these important events virtually or in a location near you.
See all events: ic-os.org/events
#cardioonc #cardiooncology #healthcareconference
The Cardio-Oncology team of Hopital Nord Marseille wishes you a Merry Christmas 🎅 and a Happy New Year. 🥳
@aphm-chu-marseille.bsky.social #CardioOnc
@aphm-chu-marseille.bsky.social #CardioOnc
December 23, 2024 at 6:08 PM
The Cardio-Oncology team of Hopital Nord Marseille wishes you a Merry Christmas 🎅 and a Happy New Year. 🥳
@aphm-chu-marseille.bsky.social #CardioOnc
@aphm-chu-marseille.bsky.social #CardioOnc
Leveraging graph networks & game theory to predict cancer therapy cardiotoxicity. Congrats Avnith, on winning a
@regeneron @Society4Science scholar award for his work in our lab, Co-mentored w/@kowingalok! Future in science is bright; great ROI➡️society tinyurl.com/4pnvvs38 #cardioonc
@regeneron @Society4Science scholar award for his work in our lab, Co-mentored w/@kowingalok! Future in science is bright; great ROI➡️society tinyurl.com/4pnvvs38 #cardioonc
January 13, 2025 at 4:37 PM
Leveraging graph networks & game theory to predict cancer therapy cardiotoxicity. Congrats Avnith, on winning a
@regeneron @Society4Science scholar award for his work in our lab, Co-mentored w/@kowingalok! Future in science is bright; great ROI➡️society tinyurl.com/4pnvvs38 #cardioonc
@regeneron @Society4Science scholar award for his work in our lab, Co-mentored w/@kowingalok! Future in science is bright; great ROI➡️society tinyurl.com/4pnvvs38 #cardioonc
#PaulKornerSeminar speaker Justin Phan: "Some cancer treatments can cause cardiac arrhythmias."
#cardioonc #Epeeps' #CardioTwitter @VandenbergJamie
#cardioonc #Epeeps' #CardioTwitter @VandenbergJamie
December 10, 2024 at 2:58 AM
#PaulKornerSeminar speaker Justin Phan: "Some cancer treatments can cause cardiac arrhythmias."
#cardioonc #Epeeps' #CardioTwitter @VandenbergJamie
#cardioonc #Epeeps' #CardioTwitter @VandenbergJamie
🚨NEW PODCAST ALERT 🚨 #Childhoodcancer treatments may produce adverse side effects that last a lifetime. Dr Eric Chow of @fredhutch.bsky.social stopped by the podcast to discuss childhood #cancer #survivorship and the unique challenges that come with it.
🎧 Tune in: tinyurl.com/mr3jh2xv
#cardioonc
🎧 Tune in: tinyurl.com/mr3jh2xv
#cardioonc
March 28, 2025 at 6:49 PM
🚨NEW PODCAST ALERT 🚨 #Childhoodcancer treatments may produce adverse side effects that last a lifetime. Dr Eric Chow of @fredhutch.bsky.social stopped by the podcast to discuss childhood #cancer #survivorship and the unique challenges that come with it.
🎧 Tune in: tinyurl.com/mr3jh2xv
#cardioonc
🎧 Tune in: tinyurl.com/mr3jh2xv
#cardioonc
Cardio Oncology Poster presentations at #AHA24 #cardioonc
November 17, 2024 at 4:24 PM
Cardio Oncology Poster presentations at #AHA24 #cardioonc
Today, we are remembering Dr Renato "Rene" Ong, a member of our Philippines chapter that tragically passed away this month.
Dr Ong was a leading researcher and advocate for #cardioonc both in the Philippines and around the world. He will be sorely missed.
Our thoughts are with his loved ones.
Dr Ong was a leading researcher and advocate for #cardioonc both in the Philippines and around the world. He will be sorely missed.
Our thoughts are with his loved ones.
September 12, 2025 at 4:20 PM
Today, we are remembering Dr Renato "Rene" Ong, a member of our Philippines chapter that tragically passed away this month.
Dr Ong was a leading researcher and advocate for #cardioonc both in the Philippines and around the world. He will be sorely missed.
Our thoughts are with his loved ones.
Dr Ong was a leading researcher and advocate for #cardioonc both in the Philippines and around the world. He will be sorely missed.
Our thoughts are with his loved ones.
🌟 New Issue 🌟 Our digital exclusive series looks at cardio-oncology from the lens of an interventional cardiologist, with expert insights on treating cancer patients in the cath lab, predictions for the next decade, & building your own practice. #cardioonc
2025 Digital Exclusive No. 2 Issue - Cardiac Interventions Today
News and information on minimally invasive coronary disease therapies, covering valvular, structural, radial access, chronic total occlusion, and imaging issues.
citoday.com
May 29, 2025 at 1:50 PM
🌟 New Issue 🌟 Our digital exclusive series looks at cardio-oncology from the lens of an interventional cardiologist, with expert insights on treating cancer patients in the cath lab, predictions for the next decade, & building your own practice. #cardioonc
GCOS 2025: Cardiac Imaging - What and When in Low-Resource Environment?
@icosociety.bsky.social
oncodaily.com/voices/gcos-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #Cardioonc #Cardiooncology #Cardiooncologia #Cardiooncologie
@icosociety.bsky.social
oncodaily.com/voices/gcos-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #Cardioonc #Cardiooncology #Cardiooncologia #Cardiooncologie
GCOS 2025: Cardiac Imaging - What and When in Low Resource Environment? - OncoDaily
GCOS 2025: Cardiac Imaging - What and When in Low Resource Environment? / cancer, GCOS, GCOS 2025, GCOS25, Ntobeko Ntusi, OncoDaily, Oncology
oncodaily.com
November 2, 2025 at 9:44 PM
GCOS 2025: Cardiac Imaging - What and When in Low-Resource Environment?
@icosociety.bsky.social
oncodaily.com/voices/gcos-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #Cardioonc #Cardiooncology #Cardiooncologia #Cardiooncologie
@icosociety.bsky.social
oncodaily.com/voices/gcos-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #Cardioonc #Cardiooncology #Cardiooncologia #Cardiooncologie
🚨 LEADERSHIP ANNOUNCEMENT 🚨
As announced at #GCOS25, Susan Dent will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley taking over the role starting in 2026.
#ThankYouDrDent #cardioonc #cardiooncology #gcos2025
As announced at #GCOS25, Susan Dent will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley taking over the role starting in 2026.
#ThankYouDrDent #cardioonc #cardiooncology #gcos2025
November 6, 2025 at 4:38 PM
🚨 LEADERSHIP ANNOUNCEMENT 🚨
As announced at #GCOS25, Susan Dent will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley taking over the role starting in 2026.
#ThankYouDrDent #cardioonc #cardiooncology #gcos2025
As announced at #GCOS25, Susan Dent will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley taking over the role starting in 2026.
#ThankYouDrDent #cardioonc #cardiooncology #gcos2025
Preventing, detecting, & managing CTR-CVT during cancer treatment is vital. A 3-part #JACCCardioOnc Expert Panel series reviews current evidence on CV care before, during, & after cardiotoxic cancer therapy, highlighting 🔑 evidence gaps acc.org/Latest-in-Ca... #CardiologyMag #CardioOnc #CardioSky
Feature | Expert Insights Into Managing Cardiotoxic Cancer Therapy - American College of Cardiology
acc.org
January 10, 2025 at 6:27 PM
Preventing, detecting, & managing CTR-CVT during cancer treatment is vital. A 3-part #JACCCardioOnc Expert Panel series reviews current evidence on CV care before, during, & after cardiotoxic cancer therapy, highlighting 🔑 evidence gaps acc.org/Latest-in-Ca... #CardiologyMag #CardioOnc #CardioSky
Delighted and deeply honoured to interview the #CardioOnc #Cardiosky superstar that is @dr_manisty on the @JACCJournals Podcast Episode: JACC: CardioOncology Pulse - Cardiovascular Considerations Before Cancer Therapy
gbr01.safelinks.protection.outlook.com?url=https%3A...
gbr01.safelinks.protection.outlook.com?url=https%3A...
Podcast Episode: JACC: CardioOncology Pulse - Cardiovascular Considerations Before Cancer Therapy
Sivatharshini Ramalingam, MD, and Charlotte Manisty, MBBS, PhD, discuss JACC: CardioOncology Expert Panel Recommendations for cardiovascular risk evaluation prior to cancer treatment, cardiac nuances ...
gbr01.safelinks.protection.outlook.com
January 7, 2025 at 9:10 AM
Delighted and deeply honoured to interview the #CardioOnc #Cardiosky superstar that is @dr_manisty on the @JACCJournals Podcast Episode: JACC: CardioOncology Pulse - Cardiovascular Considerations Before Cancer Therapy
gbr01.safelinks.protection.outlook.com?url=https%3A...
gbr01.safelinks.protection.outlook.com?url=https%3A...
It was an honor to give cardiology grand rounds @umichCVC! I really enjoyed my visit, and it was exciting to share our recent work in the field of #cardioonc/#cardioimmunology and talk to new collaborators. Thanks so much for the warm welcome, and I look forward to future visits!
February 13, 2025 at 7:50 PM
It was an honor to give cardiology grand rounds @umichCVC! I really enjoyed my visit, and it was exciting to share our recent work in the field of #cardioonc/#cardioimmunology and talk to new collaborators. Thanks so much for the warm welcome, and I look forward to future visits!